Saphris and Schizophrenia
Links shared publicly online about this topic
Saphris Approved for Schizophrenia and Bipolar Disorder
halifaxhealth.org — “Saphris Approved for Schizophrenia and Bipolar Disorder” View full resource at halifaxhealth.org
Most Recently Shared on August 14, 2009 at 7:37 pm By:
Halifax Health Healthcare System
Saphris Approved for Schizophrenia and Bipolar Disorder http://bit.ly/XBhtu
Saphris approved for schizophrenia and bipolar I disorder - MPR
empr.com — “The FDA has approved Saphris (asenapine sublingual tablets, from Schering-Plough), a psychotropic agent, for the acute treatment of schizophrenia in adults and the acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.” View full resource at empr.com
Most Recently Shared on August 14, 2009 at 3:41 pm By:
MPR News: Saphris approved for schizophrenia and bipolar I disorder: The FDA has approved Saphris (asen.. http://bit.ly/A4RkP
Saphris gains indications - MPR
empr.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at empr.com
Most Recently Shared on January 25, 2011 at 7:25 pm By:
MPR News: Saphris gains indications: Merck announced that Saphris (asenapine sublingual tablets) has been approv... http://bit.ly/i8jUas
Saphris gains indications - ONA
oncologynurseadvisor.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 7:47 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Saphris gains indications http://goo.gl/fb/fG2TE
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
medicalnewstoday.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder i” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2009 at 12:35 pm By:
psychiatryrounds Psychiatry and Support
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder: The U.S. Food and Drug Adm.. http://bit.ly/ePdzL
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Presented At ECNP
medicalnewstoday.com — “Schizophrenia is a difficult condition for patients and their families to manage. relapse is a frequent occurrence, particularly if patients decide to discontinue antipsychotic drug treatment beca” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2009 at 7:10 pm By:
psychiatryrounds Psychiatry and Support
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Pr.. http://bit.ly/SYW4n
Treatment With SAPHRIS® (asenapine) Sublingual Tablets
saphris.com — “SAPHRIS medication is commonly used to treat bipolar I disorder and schizophrenia in adults. Visit SAPHRIS and learn more about common symptoms and treatment.” View full resource at saphris.com
Most Recently Shared on July 15, 2010 at 5:44 pm By:
HealthEd Health Business and Medical Education
We're pleased and proud to announce the launch of http://www.saphris.com
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder | Psydir News
news.psydir.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.” View full resource at news.psydir.com
Most Recently Shared on August 16, 2009 at 12:31 pm By:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder http://ow.ly/15Ldfh
FDA gives Merck schizophrenia drug Saphris approval for ongoing treatment, second new use | StarTribune.com
startribune.com — “TRENTON, N” View full resource at startribune.com
Most Recently Shared on September 7, 2010 at 7:29 pm By:
FDA gives Merck schizophrenia drug Saphris approval for ongoing treatment, second new use: http://bit.ly/akcbOb
Schering-Plough Announces FDA Approval of Saphris (asenapine)
drugs.com — “Saphris (asenapine) is used to treat schizophrenia and bipolar I disorder. Includes Saphris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 6:07 am By:
Schering-Plough Announces FDA Approval of Saphris (asenapine) - http://bit.ly/XvAmd
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Presented At ECNP | Psydir News
news.psydir.com — “Schizophrenia is a difficult condition for patients and their families to manage. Relapse is a frequent occurrence, particularly if patients decide to discontinue antipsychotic drug treatment because of unwanted side effects. Psychiatrists say over half of patients relapse within two years and over 80 per cent within five years. Relapse is five times more likely to occur among patients who stop th...” View full resource at news.psydir.com
Most Recently Shared on September 18, 2009 at 8:52 pm By:
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Prese... http://ow.ly/15PJbX
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
drugs.com — “Saphris (asenapine) is used for the treatment of schizophrenia and bipolar I disorder. Saphris information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 1:14 am By:
Drugs and Devices OW OW Health
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asen... http://bit.ly/cBfzbG #drug
Bipolar disorder and schizophrenia get new drug in U.S. by end of 2009 (asenapine-Saphris) http://bit.ly/pmT4H
billyateshttp — “Bipolar disorder and schizophrenia get new drug in U.S. by end of 2009 (asenapine-Saphris) http://bit.ly/pmT4H” View full resource at billyateshttp
Most Recently Shared on September 7, 2009 at 2:34 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Bipolar disorder and schizophrenia get new drug in U.S. by end of 2009 (asenapine-Saphris) http://bit.ly/pmT4H
Saphris: It's Different without Actually Being Different | Psydir News
news.psydir.com — “On August 14th, the FDA approved Schering-Plough's second generation antipsychotic drug Saphris (asenapine) for the acute treatment of schizophrenia, and the acute treatment of mania/mixed episodes associated with bipolar I disorder (1). Question: Should I, at all be concerned that there are more actual published peer-reviewed articles of this drug being tested in rats (2, 3, 4, 5, 6 ) than in hum...” View full resource at news.psydir.com
Most Recently Shared on September 4, 2009 at 11:34 am By:
Saphris: It's Different without Actually Being Different http://ow.ly/15NICd
Saphris Bipolar Medication | Atypical Antipsychotic | Bipolar Disorder For Dummies | Bipolar Beat
blogs.psychcentral.com — “Candida Fink, MD, discusses the use of a newer atypical antipsychotic called Saphris in treating bipolar mania.” View full resource at blogs.psychcentral.com
Most Recently Shared on September 9, 2010 at 3:10 pm By:
Bipolar Beat: Bipolar Disorder Medication Spotlight: Saphris http://bit.ly/bAdqvl
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Halifax Health
For over 80 years, Halifax Health has provided high-quality health care to East Central Florida.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
